Ironwood Pharmaceuticals (IRWD) Short term Debt (2016 - 2026)

Ironwood Pharmaceuticals has disclosed Short term Debt across 9 years of filings, most recently posting $199.9 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $199.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $199.9 million (changed N/A YoY), and the FY2025 annual result was $199.7 million, changed N/A from the prior year.
• Short term Debt came in at $199.9 million for Q1 2026 at Ironwood Pharmaceuticals, roughly flat from $199.7 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $199.9 million in Q1 2026 to a low of $120.6 million in Q1 2022.
• The 5-year median for Short term Debt is $199.5 million (2025), against an average of $190.7 million.